Retatrutide

R1595

Retatrutide is an experimental triple hormone receptor agonist (GLP-1, GIP, and glucagon) developed for obesity treatment. It works by targeting three metabolic pathways simultaneously, making it one of the most potent fat loss compounds in development. Clinically shown to deliver up to 24% body weight reduction in trials.